Covid-19-cardiovascular-disease patients treating with nirmatrelvir/ritonavir inducing cardiovasculardrug interactions

Cheepsattayakorn, Attapon

doi:10.15406/jlprr.2022.09.00282

JLPRR

2022

DOI: 10.15406/jlprr.2022.09.00282

|View full text |Cite

Covid-19-cardiovascular-disease patients treating with nirmatrelvir/ritonavir inducing cardiovasculardrug interactions

Attapon Cheepsattayakorn¹

Abstract: Figure 1 Demonstrating the algorithm for proposed decision-making for Covid-19-CVD patients with NMVR need. Source: Cardiovascular drug interactions with nirmatrelvir/ritonavir in patients with COVID-19 : JACC review topic of the week. JACC. 2022. 3

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Publication Types

Select...

Relationship

Self Cite0

Independent0

Authors

Journals

Cited by 0 publications

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

No citations

Set email alert for when this publication receives citations?

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Covid-19-cardiovascular-disease patients treating with nirmatrelvir/ritonavir inducing cardiovasculardrug interactions

Abstract: Figure 1 Demonstrating the algorithm for proposed decision-making for Covid-19-CVD patients with NMVR need. Source: Cardiovascular drug interactions with nirmatrelvir/ritonavir in patients with COVID-19 : JACC review topic of the week. JACC. 2022. 3

Cited by 0 publications

References 2 publications

No citations

Contact Info

Product

Resources

About